ASPIRIN DELAYED-RELEASE TABLETS. Key specifications include administration: ORAL, primary_container_type: BOTTLE, protective_storage_feature: EXPIRATION DATED, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 12, primary_container_content_quantity: 250.000 TABLETS. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-380-9505, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| primary_container_type | BOTTLE |
| protective_storage_feature | EXPIRATION DATED |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 12 |
| primary_container_content_quantity | 250.000 TABLETS |
| active_medicament_medicinal_strength | 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | ASPIRIN DELAYED-RELEASE TABLETS USP 325MG 250S 12S PER PG |
| NSN | 6505-01-380-9505 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT |
| PRIMARY CONTAINER TYPE | BOTTLE |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| ADMINISTRATION | ORAL |
| PROTECTIVE STORAGE FEATURE | EXPIRATION DATED |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ASPIRIN DELAYED-RELEASE TABLETS USP 325MG 250S 12S PER PG |
| TOTAL PRIMARY CONTAINER QUANTITY | 12 |
| PRIMARY CONTAINER CONTENT QUANTITY | 250.000 TABLETS |